Bay Area-based Theranos is coming under scrutiny after a Wall Street Journal article questioned the accuracy of the company's blood-testing technology. Since the article, plans for a $350 million partnership with Safeway fell through. Theranos, which is valued at $9 billion, hired a high-profile Supreme Court lawyer and is weighing a defamation lawsuit against the paper. We'll get the latest on Theranos and its recent interactions with the FDA and Capitol Hill.
Theranos Under Scrutiny After WSJ Criticism
(Andrew Burton/Getty Images)